| Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 … S Sivaprasad, AT Prevost, JC Vasconcelos, A Riddell, C Murphy, J Kelly, ... The Lancet 389 (10085), 2193-2203, 2017 | 400 | 2017 |
| Twenty-four-hour intraocular pressure control with bimatoprost and the bimatoprost/timolol fixed combination administered in the morning, or evening in exfoliative glaucoma AGP Konstas, G Hollo, D Mikropoulos, S Tsironi, AB Haidich, ... British journal of ophthalmology 94 (2), 209-213, 2010 | 67 | 2010 |
| The concept of virtual clinics in monitoring patients with age‐related macular degeneration KT Tsaousis, T Empeslidis, VE Konidaris, B Kapoor, J Deane Acta Ophthalmologica 94 (5), e353-e355, 2016 | 46 | 2016 |
| Dexamethasone intravitreal implant for idiopathic retinal vasculitis, aneurysms, and neuroretinitis T Empeslidis, S Banerjee, A Vardarinos, AGP Konstas European Journal of Ophthalmology 23 (5), 757-760, 2013 | 37 | 2013 |
| 24-month clinical outcomes of a treat-and-extend regimen with ranibizumab for wet age-related macular degeneration in a real life setting A Vardarinos, N Gupta, R Janjua, A Iron, T Empeslidis, KT Tsaousis BMC ophthalmology 17, 1-7, 2017 | 36 | 2017 |
| 24-h Intraocular pressure control with evening-dosed travoprost/timolol, compared with latanoprost/timolol, fixed combinations in exfoliative glaucoma AGP Konstas, DG Mikropoulos, TA Embeslidis, AT Dimopoulos, ... Eye 24 (10), 1606-1613, 2010 | 28 | 2010 |
| Development of macular atrophy in patients with wet age-related macular degeneration receiving anti-VEGF treatment A Foss, T Rotsos, T Empeslidis, V Chong Ophthalmologica 245 (3), 204-217, 2022 | 26 | 2022 |
| 24-hour efficacy of the bimatoprost–timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma AGP Konstas, G Holló, DG Mikropoulos, AB Haidich, AT Dimopoulos, ... British Journal of Ophthalmology 97 (7), 857-861, 2013 | 24 | 2013 |
| How successful is switching from bevacizumab or ranibizumab to aflibercept in age-related macular degeneration? A systematic overview T Empeslidis, M Storey, T Giannopoulos, V Konidaris, PG Tranos, ... Advances in Therapy 36, 1532-1548, 2019 | 23 | 2019 |
| Real-world cost savings demonstrated by switching patients with refractory diabetic macular edema to intravitreal fluocinolone acetonide (Iluvien): a retrospective cost … SW Ch’ng, AJ Brent, T Empeslidis, V Konidaris, S Banerjee Ophthalmology and Therapy 7, 75-82, 2018 | 23 | 2018 |
| Intravitreal aflibercept treatment of retinal angiomatous proliferation: a pilot study and short-term efficacy KT Tsaousis, VE Konidaris, S Banerjee, T Empeslidis Graefe's Archive for Clinical and Experimental Ophthalmology 253, 663-665, 2015 | 23 | 2015 |
| Fourth cranial nerve palsy and bilateral acute retinal necrosis following human herpesvirus 6 infection of the central nervous system E Papageorgiou, S Ch'ng, A Kulkarni, S Anwar, T Empeslidis Ocular Immunology and Inflammation 22 (3), 228-232, 2014 | 21 | 2014 |
| Kyrieleis plaques in herpes zoster virus-associated acute retinal necrosis: a case report T Empeslidis, V Konidaris, A Brent, A Vardarinos, J Deane Eye 27 (9), 1110-1112, 2013 | 21 | 2013 |
| Intravitreal ranibizumab in the treatment of butterfly-shaped pattern dystrophy associated with choroidal neovascularization: a case report T Empeslidis, A Vardarinos, J Deane, S Banerjee Case Reports in Ophthalmology 3 (1), 77-82, 2012 | 18 | 2012 |
| Microperimetry in Best vitelliform macular dystrophy MB Parodi, N Castellino, P Iacono, I Chowers, T Empeslidis, M Goldstein, ... Retina 38 (4), 841-848, 2018 | 17 | 2018 |
| Incidence of retinal pigment epithelial tears and associated risk factors after treatment of age-related macular degeneration with intravitreal anti-VEGF injections T Empeslidis, A Vardarinos, V Konidaris, SW Ch'ng, B Kapoor, J Deane, ... The Open Ophthalmology Journal 8, 101, 2014 | 15 | 2014 |
| Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab V Konidaris, Z Al-Hubeshy, KT Tsaousis, K Gorgoli, S Banerjee, ... International Ophthalmology 38, 207-213, 2018 | 14 | 2018 |
| Use of intravitreal bevacizumab in a 9-year-old child with choroidal neovascularization associated with autosomal recessive bestrophinopathy RN Hussain, FL Shahid, T Empeslidis, SW Ch’ng Ophthalmic genetics 36 (3), 265-269, 2015 | 14 | 2015 |
| Comparing different dosing regimens of bevacizumab in the treatment of neovascular macular degeneration: study protocol for a randomised controlled trial AJE Foss, M Childs, BC Reeves, T Empeslidis, P Tesha, S Dhar-Munshi, ... Trials 16, 1-9, 2015 | 12 | 2015 |
| Long-term results of intravitreal bevacizumab and dexamethasone for the treatment of punctate inner choroidopathy associated with choroidal neovascularization: A case series KT Tsaousis, M Nassr, B Kapoor, VE Konidaris, S Tyradellis, T Empeslidis SAGE Open Medical Case Reports 6, 2050313X18772478, 2018 | 10 | 2018 |
